Dian Diagnostics Group Co Ltd
SZSE:300244
Intrinsic Value
Dian Diagnostics Group Co. Ltd. engages in the sale, outsourcing, research and development of medical diagnostic product and services. [ Read More ]
The intrinsic value of one
Dian Diagnostics Group Co Ltd
stock under the Base Case scenario is
38.59
CNY.
Compared to the current market price of 14.36 CNY,
Dian Diagnostics Group Co Ltd
is
Undervalued by 63%.
Dian Diagnostics Group Co Ltd's market capitalization is 9B CNY.
Dian Diagnostics Group Co Ltd stock price is 14.36 CNY.
Dian Diagnostics Group Co Ltd stock price (14.36 CNY) is 63% less than its Intrinsic Value (38.59 CNY).
Dian Diagnostics Group Co Ltd stock price (14.36 CNY) is 53% less than its DCF Value (30.64 CNY). Open DCF Valuation
Dian Diagnostics Group Co Ltd stock price (14.36 CNY) is 69% less than its Relative Value (46.54 CNY). Open Relative Valuation
Dian Diagnostics Group Co Ltd has upside potential of 116% compared to the average analyst price target.
Open Wall St Estimates
Dian Diagnostics Group Co Ltd's Altman Z-Score is equal to 2.48.
Dian Diagnostics Group Co Ltd has positive Net Debt. This means that the company has more debt (5B CNY) than cash and short-term investments (3B CNY).
Dian Diagnostics Group Co Ltd has negative Net Income for the last twelve months.
Dian Diagnostics Group Co Ltd has positive Operating Income for the last twelve months.
Dian Diagnostics Group Co Ltd's Revenue is forecast to fall at a rate of 4% per year over the next 3 years.
Dian Diagnostics Group Co Ltd has positive three-year average ROIC (Return on Invested Capital): 15%. The company is efficient at using invested capital to generate operating income.
Dian Diagnostics Group Co Ltd has positive Free Cash Flow for the last twelve months.
Dian Diagnostics Group Co Ltd's Revenue has been growing by 15% per year for the last 3 years.
Dian Diagnostics Group Co Ltd's long-term assets (20B CNY) exceed its long-term liabilties (12B CNY).
Dian Diagnostics Group Co Ltd's Revenue has dropped by 23% over the past 12 months.
Dian Diagnostics Group Co Ltd's ROIC (Return on Invested Capital) for the past 12 months is negative and is equal to -6%.
Dian Diagnostics Group Co Ltd's ROE (Return on Equity) for the past 12 months is negative and is equal to -6%.
Dian Diagnostics Group Co Ltd has positive three-year average ROE (Return on Equity): 19%. The company is efficient at transforming stockholders' equity into net income.
Dian Diagnostics Group Co Ltd's ROE (Return on Equity) has significantly decreased in the last 3 years from 25% to -6%.
Dian Diagnostics Group Co Ltd's ROIC (Return on Invested Capital) has significantly decreased in the last 3 years from 17% to -6%.
Dian Diagnostics Group Co Ltd has positive Gross Profit for the last twelve months.
Dian Diagnostics Group Co Ltd's D/E (Debt to Equity) is very low and is equal to 0.61.
Dian Diagnostics Group Co Ltd's short-term assets (16B CNY) exceed its short-term liabilties (6B CNY).
Valuation Backtest
Dian Diagnostics Group Co Ltd
Run backtest to discover the historical profit from buying and selling
Dian Diagnostics Group Co Ltd
stocks based on their intrinsic value.
Analyze the historical link between intrinsic value and market price to make more informed investment decisions.
Fundamental Analysis
Dian Diagnostics Group Co Ltd
Balance Sheet Decomposition
Dian Diagnostics Group Co Ltd
| Current Assets | 15.6B |
| Cash & Short-Term Investments | 3.2B |
| Receivables | 10.1B |
| Other Current Assets | 2.3B |
| Non-Current Assets | 4.2B |
| Long-Term Investments | 698.7m |
| PP&E | 2B |
| Intangibles | 1B |
| Other Non-Current Assets | 518.8m |
| Current Liabilities | 5.9B |
| Accounts Payable | 2B |
| Accrued Liabilities | 704.9m |
| Short-Term Debt | 1.7B |
| Other Current Liabilities | 1.4B |
| Non-Current Liabilities | 6.2B |
| Long-Term Debt | 3B |
| Other Non-Current Liabilities | 3.2B |
Earnings Waterfall
Dian Diagnostics Group Co Ltd
|
Revenue
|
14.9B
CNY
|
|
Cost of Revenue
|
-10.5B
CNY
|
|
Gross Profit
|
4.4B
CNY
|
|
Operating Expenses
|
-3.7B
CNY
|
|
Operating Income
|
709m
CNY
|
|
Other Expenses
|
-1.2B
CNY
|
|
Net Income
|
-462.7m
CNY
|
Free Cash Flow Analysis
Dian Diagnostics Group Co Ltd
What is Free Cash Flow?
Profitability Score
Profitability Due Diligence
Dian Diagnostics Group Co Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Score
Dian Diagnostics Group Co Ltd's profitability score is 48/100. The higher the profitability score, the more profitable the company is.
Solvency Score
Solvency Due Diligence
Dian Diagnostics Group Co Ltd's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Score
Dian Diagnostics Group Co Ltd's solvency score is 58/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
Price Targets Summary
Dian Diagnostics Group Co Ltd
According to Wall Street analysts, the average 1-year price target for
Dian Diagnostics Group Co Ltd
is 31.06 CNY
with a low forecast of 25.25 CNY and a high forecast of 42 CNY.
Shareholder Return
Price
Dian Diagnostics Group Co Ltd
| Average Annual Return | 9.61% |
| Standard Deviation of Annual Returns | 31.84% |
| Max Drawdown | -71% |
| Market Capitalization | 9B CNY |
| Shares Outstanding | 626 898 036 |
| Percentage of Shares Shorted |
N/A
|
Company Profile
Dian Diagnostics Group Co Ltd
Country
Industry
Market Cap
Dividend Yield
Description
Dian Diagnostics Group Co. Ltd. engages in the sale, outsourcing, research and development of medical diagnostic product and services. The company is headquartered in Hangzhou, Zhejiang and currently employs 11,123 full-time employees. The company went IPO on 2011-07-19. The firm's main business involves inspection services, product services, health management, judicial expertise, contract research organization (CRO), cold chain logistics and other fields. The firm's business is mainly oriented to medical and health institutions at all levels, such as various general and specialized hospitals, community health service centers, township (town) health centers, physical examination centers, disease prevention and control centers, etc. The firm's products include Atomic Bomb in the field of liquid phase mass spectrometry, Hydrogen Bomb in the field of nucleic acid mass spectrometry, and Man-Made Satellite in the field of pathological diagnosis products and molecular diagnosis products, and others.
Contact
IPO
Employees
Officers
The intrinsic value of one
Dian Diagnostics Group Co Ltd
stock under the Base Case scenario is
38.59
CNY.
Compared to the current market price of 14.36 CNY,
Dian Diagnostics Group Co Ltd
is
Undervalued by 63%.
You don't have any saved screeners yet
